For providers · Clinical resource
Breastfeeding and psychiatric medication: the evidence
Clinically reviewed by Josephine W. Hazeley, PMHNP-BC on · Last updated
For most psychiatric medications, breastfeeding is not automatically off the table — the decision rests on the specific drug, the infant, and the mother’s clinical need, weighed against the real value of both effective treatment and breast milk. A blanket “stop the medication” or “stop breastfeeding” reflex is rarely the evidence-based answer, and it can leave a mother untreated at the highest-risk point in the perinatal timeline.
This page is an evidence framework for referring providers, not an individualized directive. The actual decision for a given patient happens in the psychiatric visit, with the patient. What follows is how a perinatal prescriber approaches the question and which sources carry the weight.
If you or someone you know is in crisis, call or text 988 (Suicide & Crisis Lifeline) or call 911. The Postpartum Support International HelpLine is 1-800-944-4773 — a support line, not an emergency service.
Why isn’t “stop breastfeeding” the default answer?
Because both sides of the ledger carry real weight. Untreated maternal depression or anxiety is not a neutral state; it affects the mother’s health, the infant’s development, and the safety of both. Breast milk has its own well-established benefits. Weighing a small, often theoretical medication exposure against those two goods is the actual clinical task, and it usually does not resolve to abrupt discontinuation of either the medication or nursing.
The exposure through milk is also frequently low. For many psychiatric medications, the amount reaching the infant through breast milk is a small fraction of the weight-adjusted maternal dose, and monitoring the infant is often more appropriate than avoiding the drug. That is a drug-by-drug judgment, not a class-wide rule, which is exactly why a specialized source matters more than a general impression.
Which evidence sources should guide the decision?
Two references do most of the work. LactMed, the NIH National Library of Medicine’s Drugs and Lactation Database, summarizes the peer-reviewed literature for a specific drug — measured milk levels, infant serum levels, reported effects, and suggested alternatives — and is updated and peer-reviewed. It is the first stop for a specific medication question. MotherToBaby fact sheets, from the Organization of Teratology Information Specialists, translate the same kind of evidence into plainer language and also run a free counseling service patients can use directly.
Clinical guidance frames the individual-drug data. ACOG’s guideline on treating mental health conditions during pregnancy and postpartum supports continuing effective treatment through the perinatal period and individualizing medication decisions rather than reflexively stopping. Read together, LactMed answers “what do we know about this drug in milk” and the guideline answers “how should that fit the patient in front of me.”
What should you tell a patient before the referral?
Keep it accurate and non-directive. A patient who wants to breastfeed while taking, starting, or restarting a psychiatric medication has a legitimate question with a real answer, and stopping her medication on her own to breastfeed is the outcome to prevent. The safest message at the referral moment is that the two are often compatible and worth a specialist conversation, not that she must choose.
Avoid giving a specific drug verdict from the referring visit. Milk-transfer data varies by medication and sometimes by the infant’s age and health, so a confident “that one is fine” or “that one is dangerous” can be wrong for the particular pairing. Hand the patient the question and a specialist who will work it through, and note the reason for referral so the prescriber starts where you left off. The broader pregnancy-side framework is in psychiatric medication in pregnancy.
Referring for a breastfeeding-and-medication question
When a patient is weighing medication against nursing, refer to a prescriber who does this weighing routinely — the value of the perinatal specialization behind PMH-C shows up most clearly here. Mindful Counseling & Wellness takes these referrals by telehealth across North Carolina. Send the patient contact and reason through the provider hub, and the medication-in-lactation conversation happens where it should: in the evaluation, with current evidence and the patient’s own goals in view.